We propose a hypothesis that HLA genotypes may impact the differences in morbidity and mortality of COVID‐19 across countries based on our preliminary data from in silico analyses, which indicated a possible association between HLA‐A*02:01 and an increased risk for COVID‐19 due to lower capacity to present SARS‐CoV‐2 antigens. This evidence concerns the gene HLA-A and COVID-19.